An Open-Label, Multicenter, Long-Term Extension Study To Assess The Safety, Efficacy, And Pharmacodynamics Of AT2101 In Adult Patients With Type 1 Gaucher Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00813865

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:50.391549+00:00

Published At

2018-08-15T00:00:00+00:00

Record Updated At

2018-08-15

Results Posted At

2018-08-15

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Gaucher Disease", "Type 1 Gaucher Disease", "Gaucher Disease, Type 1"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2018-08-15"

protocolSection.identificationModule.nctId

"NCT00813865"

protocolSection.identificationModule.officialTitle

"An Open-Label, Multicenter, Long-Term Extension Study To Assess The Safety, Efficacy, And Pharmacodynamics Of AT2101 In Adult Patients With Type 1 Gaucher Disease"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2018-08-15"

Study condition terms

• Gaucher Disease (protocolSection.conditionsModule.conditions)
• Type 1 Gaucher Disease (protocolSection.conditionsModule.conditions)
• Gaucher Disease, Type 1 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.